PMID- 19142596 OWN - NLM STAT- MEDLINE DCOM- 20090828 LR - 20201209 IS - 1615-6722 (Electronic) IS - 0723-5003 (Linking) VI - 104 IP - 1 DP - 2009 Jan 15 TI - [Cryptococcal meningoencephalitis related to HIV infection with resistance to fluconazole, relapse, and IRIS]. PG - 58-62 LID - 10.1007/s00063-009-1007-9 [doi] AB - HISTORY AND CLINICAL FINDINGS: A 24-year-old HIV-positive patient was admitted to hospital on account of increasing headache. INVESTIGATIONS: On admission, a patient with severe headache, nausea and vomiting but without neurologic deficiencies was seen. The diagnosis of a cryptococcal meningoencephalitis could be confirmed by direct detection of cryptococci in the liquor. TREATMENT AND COURSE: The patient was treated with a combination of fluconazole, flucytosine and amphotericin B, and an antiretroviral therapy (ART) was started on account of the severe immunodeficiency. The patient improved during the following weeks, and fluconazole was administered as maintainance therapy. About 2 months later, the patient presented again with severe headache. On lumbar puncture, a great amount of cryptococci could be detected, and the antimycotic combination therapy was restarted. An antimycotic testing of the cryptococci revealed a partial resistance to fluconazole. Therefore, fluconazole was replaced by voriconazole which has been continued ever since. Cryptococci could not be detected on further investigations of the liquor. The patient's condition worsened again 8 months after initiation of the ART. MR scan showed a slight cerebral edema. There was no hint of an opportunistic infection nor of a lymphoma. The complaints were supposed to be due to an immune restoration inflammatory syndrome (IRIS), and administration of high steroid dosages was started. The complaints resolved within 48 h, and the patient's condition has been stable ever since (19 months). CONCLUSION: Cryptococcal meningoencephalitis is an opportunistic infection in AIDS. Therapeutically, various regimens containing two to three different antimycotic drugs show good efficacy but resistance to antimycotics has to be considered. As in other HIV associated infections, an IRIS has to be taken into account. FAU - Seilmaier, Michael AU - Seilmaier M AD - Medizinische Klinik, Klinik fur Hamatologie, Onkologie, Immunologie, Palliativmedizin, Klinikum Schwabing, Stadtisches Klinikum Munchen GmbH, Akademisches Lehrkrankenhaus der Ludwig-Maximilians-Universitat Munchen, Munchen, Germany. Seilmaier@lycos.de FAU - Hecht, Anna AU - Hecht A FAU - Guggemos, Wolfgang AU - Guggemos W FAU - Rudisser, Klaus AU - Rudisser K LA - ger PT - Case Reports PT - Journal Article TT - Kryptokokkenmeningoenzephalitis bei einem HIV-positiven Patienten mit Rezidiv bei Resistenz gegenuber Fluconazol und IRIS. DEP - 20090114 PL - Germany TA - Med Klin (Munich) JT - Medizinische Klinik (Munich, Germany : 1983) JID - 8303501 RN - 0 (Anti-HIV Agents) RN - 0 (Antifungal Agents) RN - 0 (Pyrimidines) RN - 0 (Triazoles) RN - 8VZV102JFY (Fluconazole) RN - JFU09I87TR (Voriconazole) SB - IM MH - AIDS-Related Opportunistic Infections/*drug therapy/microbiology MH - Adult MH - Anti-HIV Agents/therapeutic use MH - Antifungal Agents/adverse effects/*therapeutic use MH - Cryptococcus neoformans/drug effects MH - *Drug Resistance, Fungal MH - Drug Therapy, Combination MH - Fluconazole/adverse effects/*therapeutic use MH - HIV Seropositivity/*drug therapy/microbiology MH - Humans MH - Male MH - Meningitis, Cryptococcal/*drug therapy/microbiology MH - Pyrimidines/adverse effects/*therapeutic use MH - Recurrence MH - Triazoles/adverse effects/*therapeutic use MH - Voriconazole EDAT- 2009/01/15 09:00 MHDA- 2009/08/29 09:00 CRDT- 2009/01/15 09:00 PHST- 2008/09/25 00:00 [received] PHST- 2008/12/02 00:00 [accepted] PHST- 2009/01/15 09:00 [entrez] PHST- 2009/01/15 09:00 [pubmed] PHST- 2009/08/29 09:00 [medline] AID - 10.1007/s00063-009-1007-9 [doi] PST - ppublish SO - Med Klin (Munich). 2009 Jan 15;104(1):58-62. doi: 10.1007/s00063-009-1007-9. Epub 2009 Jan 14.